Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
SiTime
SITM
$20.7B
| $3.07M | ﹤0.01% |
26,000
-27,500
| -51% | -$3M |
|
1727
Vera Bradley
VRA
$94.7M
| $3.06M | ﹤0.01% |
479,702
+278,902
| +139% | +$1.57M |
|
|
OLPX
1728
DELISTED
Olaplex Holdings
OLPX
| $3.06M | ﹤0.01% |
823,300
+197,800
| +32% | +$725K |
|
1729
Disc Medicine
IRON
$3.07B
| $3.06M | ﹤0.01% |
68,890
+53,620
| +351% | +$1.9M |
|
1730
Ligand Pharmaceuticals
LGND
$5.76B
| $3.06M | ﹤0.01% |
42,400
+12,600
| +42% | +$945K |
|
|
ITIC
1731
Investors Title Co
ITIC
$534M
| $3.05M | ﹤0.01% |
20,900
-200
| -0.9% | -$28.3K |
|
1732
Akebia Therapeutics
AKBA
$241M
| $3.05M | ﹤0.01% |
3,330,727
+992,227
| +42% | +$958K |
|
1733
Greif Class B
GEF.B
$4.22B
| $3.04M | ﹤0.01% |
39,419
+14,909
| +61% | +$1.14M |
|
1734
Air T
AIRT
$78.1M
| $3.04M | ﹤0.01% |
121,111
-1,600
| -1% | -$41K |
|
1735
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
| $3.03M | ﹤0.01% |
+85,800
| New | +$3.01M |
|
|
ACB
1736
Aurora Cannabis
ACB
$235M
| $3.02M | ﹤0.01% |
564,583
-16,280
| -3% | -$96K |
|
1737
Transact Technologies
TACT
$52.5M
| $3.01M | ﹤0.01% |
336,237
+16,000
| +5% | +$113K |
|
1738
Gorman-Rupp
GRC
$2.11B
| $3.01M | ﹤0.01% |
104,300
-41,115
| -28% | -$1.05M |
|
1739
SmartFinancial
SMBK
$899M
| $3M | ﹤0.01% |
139,674
+300
| +0.2% | +$6.55K |
|
|
CHMI
1740
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $2.99M | ﹤0.01% |
619,884
-75,000
| -11% | -$386K |
|
1741
LivePerson
LPSN
$35.9M
| $2.99M | ﹤0.01% |
+44,053
| New | +$2.86M |
|
1742
Oil States International
OIS
$526M
| $2.98M | ﹤0.01% |
399,386
-68,300
| -15% | -$499K |
|
1743
DLH Holdings
DLHC
$68.7M
| $2.98M | ﹤0.01% |
290,927
-18,741
| -6% | -$192K |
|
1744
Planet Fitness
PLNT
$3.71B
| $2.97M | ﹤0.01% |
44,100
+13,800
| +46% | +$989K |
|
|
TDAY
1745
USA Today Co
TDAY
$1B
| $2.97M | ﹤0.01% |
1,321,217
+816,617
| +162% | +$1.63M |
|
1746
CION Investment
CION
$382M
| $2.97M | ﹤0.01% |
286,088
-94,112
| -25% | -$928K |
|
1747
PagSeguro Digital
PAGS
$2.43B
| $2.97M | ﹤0.01% |
314,364
-625,975
| -67% | -$6.34M |
|
|
CBAY
1748
DELISTED
Cymabay Therapeutics
CBAY
| $2.96M | ﹤0.01% |
270,020
-211,480
| -44% | -$1.97M |
|
|
RAD
1749
DELISTED
Rite Aid Corporation
RAD
| $2.96M | ﹤0.01% |
1,957,990
+972,900
| +99% | +$1.95M |
|
1750
Mesa Laboratories
MLAB
$633M
| $2.96M | ﹤0.01% |
23,000
+13,300
| +137% | +$2.03M |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.